GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $429,472 (100.0% shares, 0.0% debt)

Holdings (36)

EXEL EXELIXIS INC 7.5%
Value ($000) $32,239 Shares 1,525,000 Est. Cost $21.82 Unrealized -14.9%
ARENA PHARMACEUTICALS INC 7.4%
Value ($000) $31,601 Shares 530,670 Est. Cost $60.39 Unrealized
KADMON HLDGS INC 6.8%
Value ($000) $29,396 Shares 3,375,000 Est. Cost $4.16 Unrealized
BCAB BIOATLA INC 5.8%
Value ($000) $24,847 Shares 844,002 Est. Cost $38.96 Unrealized 0.0%
RCKT ROCKET PHARMACEUTICALS INC 5.3%
Value ($000) $22,866 Shares 765,000 Est. Cost $38.30 Unrealized -5.0%
MGNX MACROGENICS INC 4.9%
Value ($000) $20,940 Shares 1,000,000 Est. Cost $18.17 Unrealized +32.6%
DICERNA PHARMACEUTICALS INC 3.8%
Value ($000) $16,128 Shares 799,999 Est. Cost $20.16 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 3.7%
Value ($000) $15,997 Shares 86,667 Est. Cost $100.63 Unrealized +95.7%
VRTX VERTEX PHARMACEUTICALS INC 3.6%
Value ($000) $15,418 Shares 85,000 Est. Cost $195.24 Unrealized 0.0%
TVTX TRAVERE THERAPEUTICS INC 3.5%
Value ($000) $15,156 Shares 625,000 Est. Cost $24.05 Unrealized -23.6%
ANAB ANAPTYSBIO INC 3.5%
Value ($000) $14,904 Shares 549,545 Est. Cost $24.35 Unrealized +4.2%
CYTK CYTOKINETICS INC 3.3%
Value ($000) $13,990 Shares 391,429 Est. Cost $29.44 Unrealized 0.0%
BIIB BIOGEN INC 3.1%
Value ($000) $13,442 Shares 47,500 Est. Cost $288.02 Unrealized +13.8%
URGN UROGEN PHARMA LTD 2.9%
Value ($000) $12,615 Shares 750,000 Est. Cost $15.85 Unrealized 0.0%
DYN DYNE THERAPEUTICS INC 2.8%
Value ($000) $12,099 Shares 745,000 Est. Cost $18.70 Unrealized -5.2%
SAGE THERAPEUTICS INC 2.8%
Value ($000) $11,920 Shares 269,010 Est. Cost $46.70 Unrealized
XENE XENON PHARMACEUTICALS INC 2.5%
Value ($000) $10,696 Shares 700,000 Est. Cost $17.38 Unrealized 0.0%
TRICIDA INC 2.1%
Value ($000) $9,159 Shares 1,974,000 Est. Cost $4.49 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 2.1%
Value ($000) $9,113 Shares 1,300,000 Est. Cost $10.19 Unrealized -26.5%
OLMA OLEMA PHARMACEUTICALS INC 2.1%
Value ($000) $9,070 Shares 329,086 Est. Cost $28.46 Unrealized -5.1%
NEKTAR THERAPEUTICS 2.1%
Value ($000) $9,064 Shares 504,691 Est. Cost $17.96 Unrealized
ACRS ACLARIS THERAPEUTICS INC 2.1%
Value ($000) $9,000 Shares 500,000 Est. Cost $16.03 Unrealized 0.0%
RFL RAFAEL HLDGS INC 2.0%
Value ($000) $8,780 Shares 285,714 Est. Cost $45.91 Unrealized 0.0%
MAGENTA THERAPEUTICS INC 2.0%
Value ($000) $8,518 Shares 1,170,000 Est. Cost $9.65 Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.8%
Value ($000) $7,635 Shares 1,500,000 Est. Cost $6.98 Unrealized -23.3%
RIGEL PHARMACEUTICALS INC 1.7%
Value ($000) $7,187 Shares 1,980,000 Est. Cost $4.17 Unrealized
AEGLEA BIOTHERAPEUTICS INC 1.7%
Value ($000) $7,155 Shares 900,000 Est. Cost $7.50 Unrealized
PHAT PHATHOM PHARMACEUTICALS INC 1.7%
Value ($000) $7,090 Shares 220,863 Est. Cost $33.23 Unrealized 0.0%
APLS APELLIS PHARMACEUTICALS INC 1.5%
Value ($000) $6,592 Shares 200,000 Est. Cost Unrealized
KINIKSA PHARMACEUTICALS LTD 1.3%
Value ($000) $5,467 Shares 480,000 Est. Cost $11.39 Unrealized
PCVX VAXCYTE INC 0.6%
Value ($000) $2,488 Shares 98,061 Est. Cost $24.24 Unrealized 0.0%
REPARE THERAPEUTICS INC 0.6%
Value ($000) $2,444 Shares 93,137 Est. Cost $31.18 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 0.6%
Value ($000) $2,395 Shares 121,342 Est. Cost $21.69 Unrealized -0.3%
FOLD AMICUS THERAPEUTICS INC 0.6%
Value ($000) $2,378 Shares 249,000 Est. Cost $9.76 Unrealized +4.8%
IFRX INFLARX NV 0.3%
Value ($000) $1,429 Shares 551,918 Est. Cost $5.12 Unrealized -48.6%
PRQR PROQR THRAPEUTICS N V 0.1%
Value ($000) $254 Shares 30,336 Est. Cost $6.53 Unrealized 0.0%